MBIO has been in the news 643% more than usual
Jun 20, 2024, 12:32 PM
-46.35%
What does MBIO do
Mustang Bio, Inc., a clinical-stage biopharmaceutical company based in Worcester, Massachusetts, specializes in developing cell and gene therapies for hematologic cancers, solid tumors, and rare genetic diseases. The company, which went public in 2017, collaborates with notable medical centers like City of Hope and Fred Hutchinson Cancer Center to advance its CAR T therapy pipeline targeting various cancer markers.
MBIO has been in the news recently: Mustang Bio, Inc. (MBIO) shares are increasing due to positive Phase 1/2 trial results for MB-106 in treating blood cancer. MBIO also entered into an agreement to sell 6,130,000 shares of common stock at $0.41 per share in a registered direct offering.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.